← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of South Australia
Adelaide
$5,177,390
Total funding
12
Grants
Funding over time
peak $986.7K · FY2013–24$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
FDA$2,924,488 · 3
DOD$1,957,690 · 8
NIH$295,212 · 1
By mechanism
U01$2,924,488 · 3
—$1,957,690 · 8
R21$295,212 · 1
Investigators at University Of South Australia
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
FINE TUNED BIOMETRIC MODELS FOR WARFIGHTERS IN AUSTERE SETTINGS$426,632
· FY2024 · Department of the Navy
A NEW CLOSED CYCLE MECHANISM TO PREVENT BIOFOULING$400,000
· FY2013 · Department of Defense
POROUS SILICON NANOPARTICLE-BASED DELIVERY OF THERAPEUTIC ANTIBODIES FOR DIABETIC WOUND REPAIR$396,952
· FY2021 · Defense Health Agency
Predicting fetal growth early in pregnancy with non-invasive MRI: Validation in a preclinical model$295,212
R21 · FY2024 · HD
REDUCING SLEEP INERTIA WITH REACTIVE COUNTERMEASURES: IMPACT OF LIGHT AND ODOR ON ALERTNESS$269,604
· FY2020 · Department of the Navy
USING MEDIATED REALITY TO REDUCE KNEE OSTEOARTHRITIS PAIN AND IMPROVE EXERCISE ENGAGEMENT$264,888
· FY2024 · Defense Health Agency
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$250,000
U01 · FY2021 · FD
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$250,000
U01 · FY2016 · FD
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$250,000
U01 · FY2018 · FD
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$250,000
U01 · FY2017 · FD
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$250,000
U01 · FY2018 · FD
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$249,994
U01 · FY2019 · FD
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$249,994
U01 · FY2020 · FD
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$249,750
U01 · FY2014 · FD
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$249,750
U01 · FY2015 · FD
Physiologically Based Biopharmaceutics and Pharmacokinetics of Drug Products for Dermal Absorption in Humans$200,000
U01 · FY2014 · FD
Physiologically Based Biopharmaceutics and Pharmacokinetics of Drug Products for Dermal Absorption in Humans$200,000
U01 · FY2016 · FD
Physiologically Based Biopharmaceutics and Pharmacokinetics of Drug Products for Dermal Absorption in Humans$200,000
U01 · FY2015 · FD
REDUCING SLEEP INERTIA WITH REACTIVE COUNTERMEASURES: IMPACT OF LIGHT, ODOR AND CAFFEINE ON ALERTNESS$189,700
· FY2021 · Department of the Navy
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$75,000
U01 · FY2022 · FD